<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>topic Procedure for ordered scale analysis in the crossover design (GLIMMIX?) in Statistical Procedures</title>
    <link>https://communities.sas.com/t5/Statistical-Procedures/Procedure-for-ordered-scale-analysis-in-the-crossover-design/m-p/668777#M31930</link>
    <description>&lt;P&gt;&lt;SPAN&gt;Hi to All!&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;Could you please help me with the&lt;/SPAN&gt;&lt;SPAN&gt;&amp;nbsp;choosing of a SAS procedure?&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;The study protocol states that:&amp;nbsp;&lt;/SPAN&gt;&lt;I&gt;"The&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/I&gt;&lt;STRONG&gt;&lt;I&gt;parameter 1&lt;/I&gt;&lt;/STRONG&gt;&lt;I&gt;&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;is ordered categorical variables. For these endpoints, the investigational product will be compared with the reference product using&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/I&gt;&lt;STRONG&gt;&lt;I&gt;a mixed ordered logistic regression model&lt;/I&gt;&lt;/STRONG&gt;&lt;I&gt;. The model will include sequence, period and treatment as fixed effects and a repeated effect for patients within sequences, using a compound symmetry covariance structure. A 5% level of significance will be used to test for differences between the two treatments."&lt;/I&gt;&lt;BR /&gt;&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;My endpoint is a scale and has values from 0 to 4.&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;This study is a crossover study, with 2 periods and 2 drugs.&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;After some literature review and seach I've realized that the best choice would be&amp;nbsp;&lt;/SPAN&gt;&lt;STRONG&gt;proc glimmix&lt;/STRONG&gt;&lt;SPAN&gt;&amp;nbsp;in this case with the following syntax:&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;&lt;STRONG&gt;proc&lt;/STRONG&gt;&amp;nbsp;&lt;STRONG&gt;glimmix&lt;/STRONG&gt;&amp;nbsp;data=t1 method=laplace;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;class SUBJID sequence period drug timepoint;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;model AVALC = sequence period drug/ CL dist=multinomial link=clogit solution ODDSRATIO;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;random timepoint/ subject=SUBJID(sequence) residual type=cs;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;estimate 'Trt vs. Control' drug&amp;nbsp;&lt;STRONG&gt;1&lt;/STRONG&gt;&amp;nbsp;-&lt;STRONG&gt;1&lt;/STRONG&gt;;&lt;BR /&gt;run;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;What do you think?&lt;/SPAN&gt;&lt;/P&gt;</description>
    <pubDate>Mon, 13 Jul 2020 11:17:25 GMT</pubDate>
    <dc:creator>AndreyMyslivets</dc:creator>
    <dc:date>2020-07-13T11:17:25Z</dc:date>
    <item>
      <title>Procedure for ordered scale analysis in the crossover design (GLIMMIX?)</title>
      <link>https://communities.sas.com/t5/Statistical-Procedures/Procedure-for-ordered-scale-analysis-in-the-crossover-design/m-p/668777#M31930</link>
      <description>&lt;P&gt;&lt;SPAN&gt;Hi to All!&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;Could you please help me with the&lt;/SPAN&gt;&lt;SPAN&gt;&amp;nbsp;choosing of a SAS procedure?&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;The study protocol states that:&amp;nbsp;&lt;/SPAN&gt;&lt;I&gt;"The&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/I&gt;&lt;STRONG&gt;&lt;I&gt;parameter 1&lt;/I&gt;&lt;/STRONG&gt;&lt;I&gt;&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;is ordered categorical variables. For these endpoints, the investigational product will be compared with the reference product using&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/I&gt;&lt;STRONG&gt;&lt;I&gt;a mixed ordered logistic regression model&lt;/I&gt;&lt;/STRONG&gt;&lt;I&gt;. The model will include sequence, period and treatment as fixed effects and a repeated effect for patients within sequences, using a compound symmetry covariance structure. A 5% level of significance will be used to test for differences between the two treatments."&lt;/I&gt;&lt;BR /&gt;&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;My endpoint is a scale and has values from 0 to 4.&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;This study is a crossover study, with 2 periods and 2 drugs.&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;BR /&gt;&lt;SPAN&gt;After some literature review and seach I've realized that the best choice would be&amp;nbsp;&lt;/SPAN&gt;&lt;STRONG&gt;proc glimmix&lt;/STRONG&gt;&lt;SPAN&gt;&amp;nbsp;in this case with the following syntax:&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;&lt;STRONG&gt;proc&lt;/STRONG&gt;&amp;nbsp;&lt;STRONG&gt;glimmix&lt;/STRONG&gt;&amp;nbsp;data=t1 method=laplace;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;class SUBJID sequence period drug timepoint;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;model AVALC = sequence period drug/ CL dist=multinomial link=clogit solution ODDSRATIO;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;random timepoint/ subject=SUBJID(sequence) residual type=cs;&lt;BR /&gt;&amp;nbsp; &amp;nbsp;estimate 'Trt vs. Control' drug&amp;nbsp;&lt;STRONG&gt;1&lt;/STRONG&gt;&amp;nbsp;-&lt;STRONG&gt;1&lt;/STRONG&gt;;&lt;BR /&gt;run;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN&gt;What do you think?&lt;/SPAN&gt;&lt;/P&gt;</description>
      <pubDate>Mon, 13 Jul 2020 11:17:25 GMT</pubDate>
      <guid>https://communities.sas.com/t5/Statistical-Procedures/Procedure-for-ordered-scale-analysis-in-the-crossover-design/m-p/668777#M31930</guid>
      <dc:creator>AndreyMyslivets</dc:creator>
      <dc:date>2020-07-13T11:17:25Z</dc:date>
    </item>
    <item>
      <title>Re: Procedure for ordered scale analysis in the crossover design (GLIMMIX?)</title>
      <link>https://communities.sas.com/t5/Statistical-Procedures/Procedure-for-ordered-scale-analysis-in-the-crossover-design/m-p/668849#M31937</link>
      <description>&lt;P&gt;METHOD=LAPLACE and the residual option in the RANDOM statement are incompatible, as are the multinomial distribution and the residual option.&amp;nbsp; You will have to use something like;&lt;/P&gt;
&lt;PRE&gt;&lt;CODE class=" language-sas"&gt;proc glimmix data=t1 method=laplace;
   class SUBJID sequence period drug timepoint;
   model AVALC = sequence period drug/ CL dist=multinomial link=clogit solution ODDSRATIO;
   random timepoint/ subject=SUBJID(sequence) type=cs;
   estimate 'Trt vs. Control' drug 1 -1;
run;&lt;/CODE&gt;&lt;/PRE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Then comes the hard part - this looks like a clinical endpoint bioequivalence protocol, so that you may need to create a confidence interval on the difference as well as a hypothesis test of no difference at 5%.&amp;nbsp; You can do Schuirman's two one-sided tests approach with two ESTIMATE statements, with a lower and upper option on each statement..&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This can be done by adding the following:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;PRE&gt;&lt;CODE class=" language-sas"&gt; estimate 'Trt vs. Control' drug 1 -1/lower alpha=0.1;
 estimate 'Trt vs. Control' drug 1 -1;/upper alpha=0.1;&lt;/CODE&gt;&lt;/PRE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;SteveDenham&lt;/P&gt;</description>
      <pubDate>Mon, 13 Jul 2020 14:39:08 GMT</pubDate>
      <guid>https://communities.sas.com/t5/Statistical-Procedures/Procedure-for-ordered-scale-analysis-in-the-crossover-design/m-p/668849#M31937</guid>
      <dc:creator>SteveDenham</dc:creator>
      <dc:date>2020-07-13T14:39:08Z</dc:date>
    </item>
  </channel>
</rss>

